Delivery Order SPE2DB22D1017-SPE2DB25FYSKL
Award Date 9/29/25
Potential Completion Date 9/30/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zortress 0.25 mg tablets in unit dose packages of 60 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $6,831.73 and is scheduled for completion by August 25, 2025. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zortress 0.5 mg tablets in unit dose packaging (60-count) under a firm fixed-price contract valued at $9,306.29, with an ultimate completion date of August 15, 2025. This non-set-aside award represents a continuation of pharmaceutical supply support through AmerisourceBergen's existing relationship with DLA. The contractor will perform at its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Zortress 0.5 mg tablets in unit dose packaging (60 count), valued at $3,677.57. This is a firm fixed price delivery order with no set-aside designation, demonstrating competitive award through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 30,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,803.97 firm fixed-price delivery order is for the supply of Zortress 0.75 mg tablet medication, with a period of performance ending on July 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORTRESS 1 MG TABLET UD 60S, a pharmaceutical product, with a ceiling value of $2,340.05 and a period of performance through July 2, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Zortress 0.25 mg tablets, a pharmaceutical product, to support federal healthcare programs. The delivery order has a ceiling value of $2,213.16 and a period of performance that ends on October 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
- The Defense Logistics Agency awarded a $2,234.77 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4561450024 Zortress 0.75 MG tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver 60 tablets of the specified medication to its Conshohocken, Pennsylvania facility by July 11, 2023 to fulfill requirements under the contract. The prime is a division of Amerisourcebergen Corporation. No subcontractors or set aside designations were identified. The Defense...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,420.39 firm-fixed-price delivery order is for the supply of the immunosuppressive drug Zortress (everolimus) 1 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This federal contract award, with the ID SPE2DB22D3009|SPE2DB25FAN26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Zortress 0.5 mg tablets, a pharmaceutical product, with a ceiling value of $15,074.60 and a completion date of January 10, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
- This federal contract award, identified as SPE2DB20D3103|SPE2DB22FP7N6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Zortress 0.5 mg tablet, a pharmaceutical product, with a ceiling value of $11,811.09 and a completion date of September 6, 2022. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating...